연구성과로 돌아가기
2020 연구성과별 연구자 정보 (348 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Im, J. P. | Im, JP | 15 | Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea | ||||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Im, J. P. | Im, JP | 15 | Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea | ||||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Park, S. J. | Park, SJ | 16 | Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul, South Korea | ||||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Byeon, J. S. | Byeon, JS | 17 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea | ||||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Myung, S. J. | Myung, SJ | 18 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea | J-5464-2012 | Myung, Sun-Jung | ||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Yang, S. K. | Yang, SK | 19 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea | ||||||
| Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study | Ye, B. D. | Ye, BD | 20 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea | AAF-4955-2020 | Ye, Byong | ||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Lee, Hyewon | Lee, H | 1 | Natl Canc Ctr, Ctr Hematol Malignancy, Goyang, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Lee, Hyewon | Lee, H | 1 | Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Kim, Yu Ri | Kim, YR | 2 | Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea | JNZ-3445-2023 | Gim, Yuri | hemakim@yuhs.ac; | |||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Kim, Soo-Jeong | Kim, SJ | 3 | Yonsei Univ, Severance Hosp, Dept Internal Med, Div Hematol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Park, Yong | Park, Y | 4 | Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Eom, Hyeon-Seok | Eom, HS | 5 | Natl Canc Ctr, Ctr Hematol Malignancy, Goyang, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Oh, Sung Yong | Oh, SY | 6 | Dong A Univ, Dept Internal Med, Coll Med, Busan, South Korea | hemakim@yuhs.ac; | |||||
| Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (vol 78, pg 238, 2019) | Kim, Hyo Jung | Kim, HJ | 7 | Hallym Univ, Sacred Heart Hosp, Div Hematol Oncol, Dept Internal Med,Coll Med, Anyang, South Korea | AAQ-3152-2020 | Kim, Hyo | hemakim@yuhs.ac; |
페이지 이동: